Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2025 10:57 ET | Source: Research and Markets

Hematology Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 192 Deals by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the report...
November 18, 2025 10:30 ET | Source: Research and Markets

Hemophilia Research Analysis Report 2025-2035: Market Advances as Leading Players Accelerate Gene Therapy Innovation and Strategic Partnerships, Led by CSL Behring, Takeda, and Pfizer

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 18, 2025 10:12 ET | Source: Research and Markets

Hemophilia A Research Report 2025-2035: Market Driven by Innovation from Alnylam, Pfizer, Roche, Novo Nordisk, and Takeda as Next-Generation Therapies and Emerging Market Expansion Bolsters Growth

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia A Market - A Global and Regional Analysis: Focus on Treatment Type, Country, and Region - Analysis and Forecast, 2025-2035" report has been...
November 18, 2025 10:10 ET | Source: Research and Markets

Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia B Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 11, 2025 13:34 ET | Source: FFF Enterprises.com

Now Accepting: Applications for the 2026 Eric Dostie Memorial College Scholarships

TEMECULA, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., is now accepting applications for its 32nd-annual Eric Dostie...
October 22, 2025 11:57 ET | Source: Spherix Global Insights

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering

EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market...
October 17, 2025 07:31 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir ImranAt the...
October 17, 2025 07:30 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit...
August 13, 2025 16:34 ET | Source: FFF Enterprises.com

2025 Winners of the 31st-Annual Eric Dostie Memorial College Scholarship Announced

TEMECULA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., is pleased to announce the names of its 2025 Eric Dostie Memorial...
June 23, 2025 04:33 ET | Source: Research and Markets

Hematology Collaboration and Licensing Agreements Analysis Report 2025 with Directory of 192 Deals by Company A-Z, Therapy Focus and Technology Type

Dublin, June 23, 2025 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the report...